.FDA declines psychedelic MDMA-assisted therapy for post-traumatic stress disorder NBC NewsF.D.A. Declines to Accept MDMA Therapy, Finding Even More Study The Nyc TimesFDA Refuses Ecstasy-Based Drug The Stock market JournalFDA refuses to authorize unique MDMA therapy to handle post-traumatic stress disorder, along with request for even more trial information CNNFDA turns down to begin with psychedelic to address post-traumatic stress disorder, calling for additional research study The Washington Blog post.